Message from the BCC Clinical Team
Thank you Petal5 and msmolly for your questions.
Prior to the NICE (National Institute for Health and Clinical Excellence) guidance on diagnosis and treatment of early breast cancer In February 2009, NICE (2002) did recommend follow-up for at least three years. However the updated guidelines no longer recommend a minimum time period for clinical follow-up.
Their recommendations now say that after treatment (chemotherapy and/or radiotherapy) is completed, follow-up care (primary, secondary or shared care) should be discussed and agreed with the patient.
This agreed plan of care should then be written up and recorded by a healthcare professional/s and a copy to be sent to the GP and a copy kept with the patient.
It is to include:
• designated named healthcare professional
• dates for review of any adjuvant therapy
• details of surveillance mammography
• contact details for immediate referral to specialist care and support services (where necessary).
This change in the guidelines is as a result of the evidence.
The evidence doesn’t support ongoing hospital appointments results in earlier detection of recurrence over GP follow-up appointments. However, the evidence does support that for some women they feel more reassured, if followed up by the hospital team, which could be the breast care nurse.
At present in the UK, surveillance with mammography is as stated in the 2009 NICE guidelines, but clinical follow-up is varied. Some women will have scheduled appointments for a specific time period, some will have an exit meeting/appointment by a specialist nurse/doctor with open access back to the team and others will be given a contact number (usually the breast care nurse) after their exit appointment.
In general Breast Cancer Care supports the NICE 2009 guidelines as it recognises individual situations and values the input of the person concerned. However, as a result of Breast Cancer Care’s Secondary Breast Cancer Taskforce, and following the NICE guidance, Breast Cancer Care developed a tool for GPs to raise their levels of awareness of the signs and symptoms of recurrence and to encourage appropriate and timely referrals. This was sent out widely and is now being turned into a handy guide for primary care clinicians that we are planning to launch in October 2011.
If you would like to discuss any of this further, you are welcome to phone our Helpline and speak with one of our experienced nurses or specially trained workers. The freephone number is 0808 800 6000 (for Text Relay prefix 18001), Monday to Friday 9am to 5pm and Saturday 9am to 2pm.